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Abstract
Astrocytes exhibit a form of excitability based on variations of intracellular Ca
2+ concentration in response to various
stimuli, including ADP, ATP, UTP and dinucleotides. Here, we investigate the presence of the recently cloned ADP-
sensitive receptors, P2Y12 and P2Y13 subtypes, which are negatively coupled to adenylate cyclase, in cerebellar
astrocytes. We checked the effect of specific agonists, 2-methylthioadenosine diphosphate (2MeSADP) and ADP, on
adenylate cyclase stimulation induced by isoproterenol. Both agonists significantly reduced the cAMP accumulation
induced by isoproterenol. The inhibitory effect was concentration-dependent with IC50 values of 46 T 13 and 23 T 14 nM
for 2MeSADP and ADP, respectively. The experiments were carried out in the presence of MRS-2179, a specific
antagonist of P2Y1 receptor, to avoid any contribution of this receptor. Using fura-2 microfluorimetry we also proved that
astrocytes responded to 2MeSADP stimulations with calcium responses in the absence and also in the presence of MRS-
2179. Both effects, inhibition of adenylate cyclase and intracellular calcium mobilization, were not modified by
2MeSAMP, an antagonist of P2Y12 receptor, suggesting that were mediated by P2Y13-like receptors.
Abbreviations: 2MeSADP – 2-methylthioadenosine diphosphate; 2MeSAMP–2-methylthioadenosine monophosphate;
MRS-2179–N6-methyl-2¶-deoxyadenosine 3¶,5¶-bisphosphate
Introduction
In recent years it has been demonstrated that astrocytes and
other glial cells play a fundamental role in brain physiol-
ogy by signalling to neurons and influencing their activity
and vice versa. ATP and other nucleotides are involved in
this neuronYglia interaction [1Y3]. The extracellular actions
of nucleotides are mediated by their interactions with
specific membrane receptors, the P2-purinoceptors, sub-
divided into ionotropic P2X and metabotropic P2Y
receptors [4]. Focusing on the metabotropic P2Y family,
it comprises two structurally distinct subfamilies [5]. The
first one is composed of P2Y1, P2Y2, P2Y4, P2Y6 and
P2Y11 receptors, that exhibited different selectivity for
adenine and uracile nucleotides, all exclusively coupled to
phospholipase C pathway, except P2Y11, which is also
positively coupled to the cAMP pathway. The second
subfamily includes P2Y12, P2Y13 receptors, both selective
for ADP, and the UDP-glucose receptor, renamed P2Y14,
which are all coupled to Gi. The identification of the P2Y12
receptor has explained several ADP actions that were not
mediated by P2Y1 receptors [6Y9]. One interesting exam-
ple is the case of platelets, in which ADP-induced
aggregation requires both P2Y1 and P2Y12 activation. In
fact, the P2Y12 receptor is the target of antithrombotic
drugs, such as clopidrogel and ATP derivatives, the AR-C
compounds, such as ARC69931MX [8, 10Y13]. Another
example is the Gi-coupled P2Y receptor distinct from
P2Y1, long known to exist in C6 glioma and B10 brain
capillary endothelial cells, which has also been identified
as P2Y12 receptor [14Y16]. Although to date there are not
many data concerning the functionality of the P2Y12 and
P2Y13 in neural cells, the high levels of expression found
in brain suggests important roles in the nervous system [7,
17Y20].
Our group has focused the investigation on the charac-
terization of nucleotide receptors in cerebellum using
purified cultures of neuronal and glial cells. We demon-
strated that the two major neuronal types present in
cerebellum, Purkinje cells and granule neurons, and
astroglia expressed functional nucleotide receptors: Pur-
kinje and granule neurons co-expressed ionotropic P2X
and metabotropic P2Y nucleotide receptors and astrocytes
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[21Y24]. Previous to the identification of the second
subfamily of P2Y receptors the presence of Gi/o-linked
ADP receptors was detected in cerebellum, which was
largely concentrated in the white matter [25, 26]. The
cloning of the new members prompted us to search their
presence in the glial cells. The current study reveals the
presence of functional Gi/o-linked ADP receptors in
cerebellar astrocytes and provides molecular and biochem-
ical evidences to suggest that these receptors are P2Y13-
like subtype.
Materials and methods
Cultures of rat cerebellar type-1 astrocytes
Type-1 astrocyte purified cultures were obtained from
cerebellum of 7- to 8-day-old rats as previously described
[27]. Cerebellar cells were dissociated by trypsin digestion
and astrocytes purified by orbital shaken. They were grown
until confluency in DMEM containing 10% (v/v) fetal calf
serum, 30 mM glucose, 50 U/ml penicillin, 50 mg/ml
streptomycin, 100 mg/ml kanamycin and 2.5 mg/ml
amphotericin at 37 -C in a humidified atmosphere of 5%
CO2/95% air. The type-1 astrocytes, finally, were passaged
by trypsinization with 0.05% trypsin and 0.002% EDTA in
phosphate-buffered saline without added Ca
2+ and Mg
2+.
Cells were plated in 24-well Petri dishes for cAMP
determinations or over 15-mm-diameter coverslips in 35-
mm Petri dishes at a density of 200,000 cells/well for
microfluorimetric and immunocytochemistry experiments.
Determinations of cAMP levels
Cells were washed for 2 h at 37 -C in 1 ml per well of
Locke’s solution (composition in mM: NaCl, 140; KCl,
4.5; CaCl2, 2.5; KH2PO4, 1.2; MgSO4, 1.2; glucose, 5.5;
HEPES (acid), 10; pH 7.4) and incubated for 30 min in the
presence of 500 mM rolipram. Then, cells were preincu-
bated with 10 mM MRS-2179 for 3 min, previous to the
stimulation with the agonists. Agonists were added for 3
min, and the incubations were terminated by addition of
6% trichloroacetic acid. Cell lysates were centrifuged at
13,000 g for 10 min at 4 -C and the cAMP levels in the
supernatants were measured using the enzyme-immuno-
assay kit from Amersham.
Calcium imaging
Cells attached to coverslips were washed with Locke’s
solution supplemented with 1 mg/ml BSA and loaded with
5 mM fura-2/AM for 45 min at 37 -C. The coverslip was
placed in a small superfusion chamber and the cells were
imaged through a NIKON TE-200 microscope with a Plan
Fluor 20 /0.5. Emitted light was isolated by a dichroic
mirror (430 nm) and a 510-nm band pass filter (Omega
Optical). The wavelength of the incoming light was selected
with the aid of a monochromator (12-nm bandwidth, Perkin
Elmer Life Sciences) set at 340 and 380 nm. Twelve-bit
images were obtained using an Ultrapix 2000 Mono CCD
camera controlled by Ultraview PC software. Exposure
time was 50 ms and change in the wavelength of
incoming light from 340 to 380 nm is carried out in less
than 5 ms. Time-course data represent the average light
intensity in a small elliptical region within each cell.
Background and autofluorescence components were sub-
tracted at each wavelength and the F340/F380 ratio was
calculated. [Ca
2+]i was derived from F340/F380 ratio using
the equation’s Grynkiewicz as previously described [21].
Rmax and Rmin parameters were obtained from an in vitro
calibration performed by recording fluorescence from
small droplets of fura-2 (free acid) dissolved in intracellu-
lar solution (in mM: 100 KCl, 10 NaCl, 1 MgCl2,1 0
MOPS and 1Y2 mM fura-2, pH 7.0) plus 2.5 mM CaCl2
(saturated Ca
2+) or 2.5 mM EGTA (zero Ca
2+). The
dissociation constant of fura-2 was assumed to be 224
nM. Drugs were applied to the cells by superfusion in
Locke’s solution at 37 -C.
Immunocytochemical experiments
For immunofluorescence assay, coverslips were fixed with
4% PFA (w/v) for 15 min, washed twice in PBS and
incubated for 1 h in PBS containing 3% BSA (w/v), 0.1%
Triton X-100 (v/v), and 5% normal goat serum (v/v). Cells
were washed twice with PBS/BSA and incubated with the
primary antibodies for 1 h at 37 -C. Primary antibodies,
diluted in PBS/BSA, recognized the specific rat proteins:
mouse anti-glial fibrillar acid protein (GFAP, 1:200,
Sigma), rabbit anti-P2Y1 (1:100, Chemicon) and anti-
P2Y12 (1:50, Alomone). Cells were then washed three
times and incubated for 1 h at 37 -C with the appropriated
secondary antibodies: Goat anti-mouse IgG fluorescein
conjugated (1:1,000, Sigma) and goat anti-rabbit IgG
rhodamine conjugated (1:500, Sigma). After this incuba-
tion, cells were washed three times and mounted following
standard procedures with Prolong antifade medium
(Molecular Probes). Controls of unspecific labeling were
made in the same experimental conditions but the primary
antibodies were replaced with the same volume of PBS/
BSA solution. Coverslips were viewed with a NIKON
microscope equipped with a 60  1.4 oil objective and
fluorescein/rhodamine filters.
RT-PCR experiments
Total RNA was isolated from astrocyte cultures from one
passage and plated onto 35-mm-diameter culture dishes,
using the RNeasy system (RNeasy extraction kit, Qiagen).
Extracted RNA was routinely submitted to digestion with
RNAse-free DNAse to eliminate traces of contaminating
genomic DNA (DNA extraction kit, Qiagen), which could
interfere in the PCR experiments. RNA was accurately
measured using the sensitive fluorescent probe Ribogreen
(RNA Quantitation Reagent, Molecular Probes).
cDNA was synthesized from 1 mg total RNA using the
MultiScribe Reverse Transcriptase (1.25 U/ml, Applied
154 L.M.G. Carrasquero et al.Biosystems), according to manufacturer instructions. Par-
allel RT reactions for each RNA sample were carried out
in the absence of the reverse transcriptase enzyme, to
evaluate the degree of genomic DNA contamination (-RT
control). For PCR reactions, 2Y5 ml of the RT reaction
product were amplified at 60 -C annealing using 0.625 U
of Ampli Taq Gold DNA polymerase (Applied Biosystems)
and specific oligonucleotide primers for P2Y receptors.
The following forward (Fw) and reverse (Rv) oligonu-
cleotide primers obtained from rat cDNA sequences were
used:
P2Y1 Fw : 50 CATTCTTTATTTCTTGGCTGGAGAT 30
Rw : 50 GAGTCATTTCTTCACTCTTGGATTGTA 30
P2Y12 Fw : 50 CAGGTTCTCTTCCCATTGCT 30
Rw : 50 CAGCAATGATGATGAAAACC 30
P2Y13 Fw : 50 TACCTCAAGAACACTCTGGTGGCAGAC 30
Rw : 50 TTCACGGATGATGGCGTTGCCTCCTTGTT 30
P2Y14 Fw : 50 TGTCTGCCGTGATCTTCT 30
Rw : 50 GGGTCCAGACACACATTG 30
Parallel PCR reactions were carried out with RT products
obtained from platelets, spleen and hippocampus as
positive expression controls for P2Y12, P2Y13 and P2Y14
receptors, respectively.
Statistical analysis
Results are represented as the means T SE calculated from
at least six experiments performed in duplicate from
different cultures. Comparisons were made by one-way
ANOVA, and Dunnett post-test analysis was only applied
when a significant (P G 0.05) main effect was indicated by
the ANOVA.
Results
To analyze the presence of Gi-linked ADP receptors in
cerebellar astrocytes, we used several strategies, RT-PCR
analysis for the detection of the mRNA codifying for
P2Y12 and P2Y13 receptors, immunocytochemical studies
to identify the corresponding proteins and biochemical and
pharmacological approaches to prove their functionality.
Expression of mRNA for P2Y1,12,13,14 receptors in
cerebellar astrocyte cultures
RT-PCR analysis showed that cerebellar astrocytes co-
expressed several P2Y receptors of the ADP receptor
family. Besides the P2Y1 receptor, whose functionality in
astrocytes has been previously demonstrated, P2Y12 and
P2Y13 mRNA were abundantly expressed in astrocytes in a
similar extent to that found in platelets and spleen, res-
pectively, in the same experimental conditions (Figure 1).
The expression of the other member of the subfamily, the
P2Y14 receptor, was also detected. In all cases the specific
bands of the PCR products were of the expected sizes and
no signals were observed in control assays in the absence
of templates.
Inhibition of cAMP production by Gi-linked ADP receptors
Based on the fact that cerebellar astrocytes possess b-
adrenergic receptors coupled to adenylate cyclase activa-
tion, the presence and functionality of Gi-linked ADP
receptors was investigated by analyzing the effect of
specific agonists on cAMP production induced by isopro-
terenol. All these experiments were carried out in the
presence of a specific antagonist of the P2Y1 receptor,
MRS-2179, to exclude any action of the agonists through
this receptor. Adenosine deaminase was also added in the
incubations to avoid any effect of the nucleoside produced
by extracellular hydrolysis of nucleotides. In previous work
we demonstrated that astrocytes possessed A2B adenosine
receptors coupled to adenylate cyclase stimulation [27].
Figure 2 shows that co-stimulation of astrocytes with
2MeSADP or ADP and isoproterenol significantly reduced
theisoproterenol-increasedcAMPlevelsinadose-dependent
manner, reaching a maximum of 40% reduction at 10 mM
concentration. The IC50 values were 46 T 13 and 23 T 14
nM for 2MeSADP and ADP, respectively. The similar
potency displayed by these agonists suggests that the ADP
receptor that mediates this inhibition was a P2Y13-like
Figure 1. Expression of mRNAs for P2Y1, P2Y12, P2Y13 and P2Y14 nucleotide receptors in cerebellar astrocyte cultures. Typical RT-PCR results
obtained from three different cultures. PCR products for P2Y1, P2Y12, P2Y13 and P2Y14 receptors in astrocytes are shown in lanes 3, 5, 8 and 11,
respectively. Expression controls were made using total RNA obtained from platelets for P2Y12 (lane 6), spleen for P2Y13 (lane 9) and hippocampus for
P2Y14 receptors (lane 12). Besides the H2O controls performed in the absence of template are shown in lanes 2, 4, 7 and 10. Band sizes were determined
using RNA standards (lanes 1 and 13).
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P2Y13 receptors we examined the action of a P2Y12 re-
ceptor antagonist, 2MeSAMP [8, 28]. Since both agonists
exhibited the same potency, and ADP can be hydrolyzed
more quickly than 2MeSADP, 2MeSADP was used in the
following experiments. Preincubation of astrocytes with
the nucleotide derivative, 2-methylthioadenosine 5¶-mono-
phosphate (2MeSAMP, 100 mM), did not revert the inhi-
bition displayed by 2MeSADP (Figure 3). The diagram
also shows that simple stimulation of astrocytes with 10
mM 2MeSADP or 100 mM 2MeSAMP did not change
basal cAMP levels. In addition, 2MeSAMP had not effect
on cAMP accumulation stimulated by isoproterenol.
Finally, it was tested whether the inhibition of adenylate
cyclase by P2Y agonists was associated with a Gai pro-
tein. For this purpose astrocytes were preincubated over-
night with 100 ng/ml pertussis toxin previous to carry out
cAMP determinations. This pretreatment completely abol-
ished the inhibitory effect of 2MeSADP, indicating the
involvement of a G protein of the PTX-sensitive Gi/Go
family (Figure 3).
2MeSADP-induced calcium responses in cerebellar
astrocytes
Given that P2Y13 receptor was also coupled to phospho-
lipase C activation and the subsequent inositol phosphate
production [7], we investigated its possible running in
cerebellar astrocytes. Cells were challenged with 10 mM
2MeSADP and single cell responses followed by micro-
fluorimetry. As expected cells responded to 2MeSADP
with rapid [Ca
2+]i transients (Figure 4). The DF340/F380
were highly variable from cell to cell ranging from 0.022 to
0.088 (0.051 T 0.002, n = 224 cells, corresponding to
[Ca
2+]i increases of 360 T 45 nM). But, surprisingly most
of tested cells also responded to 2MeSADP stimulations in
the presence of the specific P2Y1 antagonist, MRS-2179,
which reveals that other ADP-sensitive receptor was being
activated. Although the magnitude of the calcium
responses observed in the presence of MRS-2179 was very
heterogeneous. We could distinguish three groups of cells:
Cells that were nearly insensitive to MRS-2179 (38% of
cell population, population A), cells partially sensitive to
MRS-2179 antagonism, which showed between 31% and
70% of control cell responses (49% of tested cells,
population B), and cells in which 2MeSADP responses
were completely abolished by MRS-2179 (13% of tested
cells, population C).The same distribution pattern of
calcium responses was obtained after preincubation with
the two antagonists MRS-2179 and 2MeSAMP.
Finally, we also carried out immunocytochemistry
experiments to detect the presence of P2Y12 protein.
Figure 5 shows that there was no specific labeling of
astrocytes with the anti-P2Y12 receptor antibody, whereas,
as expected, a specific staining was observed with the anti-
P2Y1 receptor antibody in the same experimental con-
ditions. Positive controls for the P2Y12 receptor detection
were made in platelets (results not shown).
Figure 2. Identification of ADP receptors that inhibit isoproterenol-activated adenylate cyclase in cerebellar astrocytes. Astrocytes were preincubated
with 10 mM MRS-2179 previous to co-stimulation for 3 min with different concentrations of purinergic agonists (2MeSADP or ADP) and 10 mM
isoproterenol, and the cAMP accumulation was calculated as described in Materials and methods. Data were normalized with respect to the control for
each experiment. Values are the means T SD of five experiments performed in triplicate. The logistic curves were fitted by non-linear regression.
Figure 3. Effect of 2MeSAMP and pertussis toxin on the 2MeSADP-
induced inhibition of cAMP production stimulated by isoproterenol in
astrocytes. To check the effect of 2MeSAMP, cells were preincubated
with 10 mM MRS-2179 and 100 mM 2MeSAMP for 3 min previous to co-
stimulation with 10 mM 2MeSADP and isoproterenol and cAMP
production measured as described in Materials and methods. Where
indicated, cells were stimulated with 10 mM 2MeSADP or 100 mM
2MeSAMP alone or in the presence of isoproterenol for 3 min. To study
the effect of pertussis toxin cells were treated overnight with 100 ng/ml
pertussis toxin. Data were normalized with respect to the controls for each
experiment. Values are the means T SD of four experiments performed in
quadruplicate from different cultures.
156 L.M.G. Carrasquero et al.Figure 4. Calcium responses elicited by 2MeSADP stimulation in single cerebellar astrocytes. Cells were loaded with fura-2 and the time-course of
fluorescence changes recorded from cells after stimulation with 10 mM of the agonist for 40 s as described in Materials and methods. Where indicated,
before cells were stimulated with 2MeSADP, they were preincubated for 3 min with 10 mM MRS-2179 in the absence (middle recordings) or presence of
100 mM 2MeSAMP (right recordings). Figure shows the calcium responses of three cells, which are representative of the cell subpopulations found with
respect to their sensitivity to MRS-2179 antagonism (represented in the diagram, n = 300 cells tested from three different cultures).
Figure 5. Fluorescence images of cerebellar astrocytes labelled with different antibodies. Panels A and C show specific anti-GFAP-FITC
immunostaining of the cells. (B) Same field as A viewed with Rhodamine optics using anti-P2Y1-TRITC reveals specific labelling of the cells. (D)
Same field as C viewed with Rhodamine optics using anti-P2Y12-TRITC shows a negative immunolabelling. These images show the purity of the
cultures, all the cells are identified as astrocytes. Bar = 20 mm.
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In the present study we show the presence of functional Gi-
linked receptors in cultured astrocytes from rat cerebellum.
The pharmacological profile of the analyzed responses to
2MeSADP and ADP suggests the involvement of P2Y13-
like receptor subtype, which represents the first report of a
functional P2Y13-like receptor expressed in native cellular
environment. The identification and characterization of Gi-
linked receptors, such as P2Y12 and/or P2Y13 in native
tissues is quite difficult, particularly when they could be
co-expressed with other P2Y subtypes, such as P2Y1.
These three subtypes are ADP receptors with similar
agonist profile (2MeSADP Q 2MeSATP 9 ADP Q ATP)
and, in addition, there are no specific antagonists for each
one of the subtypes. Whereas P2Y1 receptor can be
selectively blocked by MRS-2179, the AR-C compounds
described as specific antagonists of P2Y12 receptor can
also act on some P2Y13 [8, 9, 29Y32]. The pharmacological
studies reported in the literature with the cloned P2Y12 and
P2Y13 receptors revealed that they could be distinguished
by the relative potency of 2MeSADP and ADP. At the
platelet P2Y12 and brain P2Y12 like receptor 2MeSADP is
more potent than ADP (two or three orders of magnitude)
and clearly differs from the P2Y13 at which both agonists
are nearly equipotent [8, 28, 30, 31]. In cerebellar
astrocytes 2MeSADP and ADP exhibited similar potency
in decreasing cAMP accumulation induced by isoprotere-
nol. Although it is not accurate to compare the relative
potency of agonists described for the different cloned
receptors, the IC50 values reported here were very similar
to those described for the human and mouse P2Y13
receptors (IC50 = 13 nM). The values are critically
dependent on the experimental conditions, such as expres-
sion levels of receptor in the different cell lines and
effector system assessed, cAMP and/or inositol phosphate
production, fluorimetric imaging plate reader assays,
binding of radiolabelled agonists, etc. The recent cloning
and pharmacological characterization of P2Y13 receptor
from rat tissues has revealed that ADP is two to three times
more potent than 2MeSADP on this receptor, which agrees
with our results [32].
Others findings that supported the involvement of a
P2Y13-like receptor are that 2MeSADP effects, both the
repression of cAMP levels and the calcium responses
recorded in the presence of MRS-2179, were not reversed
by 2MeSAMP, which is a selective antagonist of P2Y12
receptor. 2MeSAMP (10 and 50 mM) completely abolished
the ADP and 2MeSADP effects mediated by the P2Y12
receptor [8]. In addition, we have not detected the presence
of P2Y12 protein by immunocytochemistry using a specific
antibody for the hP2Y12, whereas the presence of P2Y1
protein was confirmed in the same experimental condi-
tions. These negative results supported the involvement of
another Gi-linked ADP receptor. Although we cannot
exclude the possibility that P2Y12 receptor could be co-
expressed in some cells in a very low quantity below
detection limit in our experimental conditions. It is
interesting to take into account that the detection of mRNA
does not always correlate with the presence of the
corresponding protein. In this sense, we have also found
by RT-PCR bands that corresponded to mRNA for some
P2X subunits (P2X1, P2X3 and P2X4) in our astrocyte
cultures (results not shown) but we have not detected any
ionotropic nucleotide responses. In contrast to these
findings, the presence of ionotropic P2X receptors in
astrocytes from other brain areas has been demonstrated
[33Y35]. This heterogeneity might be related to the need to
regulate the different neurotransmission types.
To conclude, the present study reveals that cerebellar
astrocytes possess at least two specific ADP receptors,
which can be simultaneously activated at nanomolar con-
centrations of the nucleotide, P2Y1 and P2Y13-like recep-
tors, coupled to phospholipase C stimulation and adenylate
cyclase inhibition, respectively (Figure 6). The question
that arises is: What is the function of these receptors
in astrocytes? As previously mentioned, it is clearly
demonstrated that P2Y1 and P2Y12 cooperate to induce
Figure 6. Schematic representation of P2Y nucleotide receptors present in cerebellar astrocytes. Astrocytes coexpressed several P2Y receptors that can
be selectively stimulated by adenine and uracile nucleotides. ADP would interact with P2Y1 and P2Y13-like receptors triggering two intracellular
signaling cascades, intracellular calcium mobilization and decreasing cAMP production.
158 L.M.G. Carrasquero et al.ADP-induced platelet aggregation, a similar cooperation
between P2Y1 and P2Y13-like receptor could be take place
in astrocytes to control metabolism, proliferation, differen-
tiation or even apoptosis depending on cellular environ-
ment or otherwise function independently. The fact that
P2Y13-like receptor stimulation also induced calcium
responses might suggest that P2Y13 would substitute
P2Y1 receptor, when the later was in inactive state.
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